Digital Evidence Base

Trusted Knowledge for Informed Decisions

Filters
SDGs
Priority Areas
Research Outcomes
Document Type
Year
4019 results found
Show:
Real-time adherence monitoring for HIV antiretroviral therapy
Haberer J E, Bangsberg D R, Emenyonu N, Kahane J, Kigozi I, Hunt P, Martin J
2010
DOI: 10.1007/s10461-010-9799-4

Current adherence assessments typically detect missed doses long after they occur. Real-time, wireless monitoring strategies for antiretroviral therapy may provide novel opportunities to proactively prevent virologic rebound and treatment failure. …

Abstract
Realtime adherence monitoring of antiretroviral therapy among HIV-infected adults and children in rural Uganda
Haberer JE, Muzoora C, Bangsberg DR, Kiwanuka J, Nansera D, Hunt PW, So J, O'Donnell M, Siedner M, Martin JN
2013
DOI: 10.1097/QAD.0b013e328363b53f

A real-time wireless electronic adherence monitor (EAM) and weekly self-report of missed doses via interactive voice response (IVR) and short message service (SMS) queries were used to measure anti-retroviral therapy …

Abstract
Duration of Antiretroviral Therapy Adherence Interruption Is Associated With Risk of Virologic Rebound as Determined by Real-Time Adherence Monitoring in Rural Uganda
Haberer JE, Siedner MJ, Boum Y, Bangsberg DR, Hunt PW, Martin JN, Musinguzi N, Mocello AR
2015

Background: Antiretroviral therapy (ART) adherence interruptions have been associated with viral rebound; however, the true risk is unknown because HIV RNA has never been measured during ongoing interruptions.Methods: The Uganda …

Abstract
Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda
Haberer J E, Bangsberg D R, Musinguzi N, Musiimenta A, Atukunda E C, Wyatt M A, Ware N C
2016
DOI: 10.1097/QAD.0000000000001021

Objective: To explore the effects of four types of short message service (SMS) plus real-time adherence monitoring on antiretroviral therapy (ART) adherence: daily reminders, weekly reminders, reminders triggered after a …

Abstract
Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: A prospective analysis of prevention-effective adherence: A
Haberer J E, Celum C, Heffron R, Katabira E, Kidoguchi L, Mugo N, Bukusi E, Asiimwe S, Thomas K K, Baeten J M
2017
DOI: 10.7448/IAS.20.1.21842

Introduction: Adherence is essential for pre-exposure prophylaxis (PrEP) to protect against HIV acquisition, but PrEP use need not be life-long. PrEP is most efficient when its use is aligned with …

Abstract
Context Matters: PrEP Adherence is Associated With Sexual Behavior Among HIV Serodiscordant Couples in East Africa
Katabira Elly, Bangsberg David R., Haberer Jessica E., Ngure Kenneth, Muwonge Timothy, Mugo Nelly, Heffron Renee, Musinguzi Nicholas, Celum Connie, Baeten Jared M.
2017
DOI: 10.1097/QAI.0000000000001548

Background: Short message service (SMS) surveys are a promising tool for understanding whether preexposure prophylaxis (PrEP) adherence aligns with risk for HIV acquisition--a concept known as prevention-effective adherence. Methods: The …

Abstract
ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa
Haberer JE, Siedner MJ, Tsai AC, Orrell C, Bangsberg DR, Matthews LT, Musinguzi N, Asiimwe S, Bwana BM, Amanyire G, Katz IT, Bell K, Kembabazi A, Mugisha S, Kibirige V, Cross A, Kelly N, Hedt-Gauthier B
2019
DOI: 10.1002/jia2.25232

IntroductionThe success of universal antiretroviral therapy (ART) access and aspirations for an AIDS-free generation depend on high adherence in individuals initiating ART during early-stage HIV infection; however, adherence may be …

Abstract
Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations
Ford Nathan, Munderi Paula, Bangsberg David R., Tsai Alexander C., HabererJessica E., Sabin Lora, Amico K. Rivet, Orrell Catherine, Galárraga Omar, Vreeman Rachel C., Wilson Ira, Sam-Agudu Nadia A., Blaschke Terrence F., Vrijens Bernard, Mellins Claude A., Remien Robert H., Weiser Sheri D., Lowenthal Elizabeth, Stirratt Michael J., Sow Papa Salif, Thomas Bruce, Mills Edward, Lester Richard, Nachega Jean B., Bwana Bosco Mwebesa, Ssewamala Fred, Mbuagbaw Lawrence, Geng Elvin
2017

MEDLINE Abstract: Introduction<BR>: Successful population-level antiretroviral therapy (ART) adherence will be necessary to realize both the clinical and prevention benefits of antiretroviral scale-up and, ultimately, the end of AIDS. Although …

Abstract
Antiretroviral therapy availability and HIV-related stigma and serostatus disclosure in Rakai, Uganda
Haberlen Sabina A.
2010

Objectives: HIV-related stigma and low rates of HIV serostatus disclosure to sexual partners affect prevention efforts and contribute to negative health and social outcomes. However, empirical data on the effects …

Abstract
Antiretroviral Therapy Availability and HIV Disclosure to Spouse in Rakai, Uganda: A Longitudinal Population-Based Study
Nakigozi G, Wawer MJ, Gray RH, Serwadda D, Nalugoda F, Kagaayi J, Ssekasanvu J, Haberlen SA, Brahmbhatt H
2015
DOI: 10.1097/QAI.0000000000000600

Background: A decade after the rollout of antiretroviral therapy (ART) in sub-Saharan Africa, the effects of this structural change on social aspects of HIV, such as rates of HIV disclosure …

Abstract
AI Research Assistant
AI-powered research assistance. Uses the Digital Evidence Base as the Knowledge source.